Iceland· IS-EU/1/22/1672/001-003
Livtencity
A maribavir product containing maribavirum inn, registered in Iceland by Takeda Pharmaceuticals International AG Ireland Branch. The same ATC class is registered in 15 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Maribavir is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AX10 (maribavir), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Maribavir · ATC J05AX10
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of maribavir costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $0.94 in France to $1342.12 in Italy — a ×1425 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Maribavir · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- IT Italy$1342.12
- CH Switzerland$975.13
- FR France$0.94
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Maribavirum INN
- Manufacturer
- Takeda Pharmaceuticals International AG Ireland Branch
- Country
- Iceland (IS)
- ATC code
- J05AX10
- ATC class
- Maribavir
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean06953856 stk x1 glasISK 1982828
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maribavir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLIVTENCITYTakeda Pharmaceuticals International AG Ireland Branch, Dublin
- SwitzerlandLivtencity 200 mg, FilmtablettenTakeda Pharma AG
- FinlandLIVTENCITYTakeda Pharmaceuticals International AG Ireland Branch
- FranceLIVTENCITY 200 mg, comprimé pelliculéTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- IrelandLIVTENCITY 200 mg film-coated tabletsTakeda Pharmaceuticals International AG Ireland Branch
- NetherlandsLivtencity 200 mg, filmomhulde tablettenShire Pharmaceuticals Ireland Limited
- NorwayLivtencityTakeda Pharmaceuticals International AG Ireland Branch
- PolandLivtencityTakeda Pharmaceuticals International AG Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Livtencity
- Norway · Livtencity
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4bfd6d92-0fb2-44f6-a1cf-feeb51e8ff0c GET /v1/drugs/4bfd6d92-0fb2-44f6-a1cf-feeb51e8ff0c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "J05AX10",
"marketed": true,
"strength": "200 mg",
"ma_number": "EU/1/22/1672/001-003",
"substance": "Maribavirum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga sem hafa reynslu af meðferð sjúklinga eftir líffæraígræðslu",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "44874"
}See everything about maribavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.